[1]EL-SERAG HB.Epidemiology of viral hepatitis and hepatocellular carcinoma[J].Gastroenterology,2012,142(6):1264-1273.
|
[2]OSAKI Y,NISHIKAWA H.Treatment for hepatocellular carcinoma in Japan over the last three decades:Our experience and published work review[J].Hepatol Res,2015,45(1):59-74.
|
[3]NISHIKAWA H,OSAKI Y.Non-B,non-C hepatocellular carcinoma(Review)[J].Int J Oncol,2013,43(5):1333-1342.
|
[4]SUZUKI Y,OHTAKE T,NISHIGUCHI S,et al.Survey of non-B,non-C liver cirrhosis in Japan[J].Hepatol Res,2013,43(10):1020-1031.
|
[5]NAGAOKI Y,HYOGO H,AIKATA H,et al.Recent trend of clinical features in patients with hepatocellular carcinoma[J].Hepatol Res,2012,42(4):368-375.
|
[6]BARVE A,KHAN R,MARSANO L,et al.Treatment of alcoholic liver disease[J].Ann Hepatol,2008,7(1):5-15.
|
[7]THOMSON SJ,WESTLAKE S,RAHMAN TM,et al.Chronic liver disease—an increasing problem:a study of hospital admission and mortality rates in England,1979-2005,with particular reference to alcoholic liver disease[J].Alcohol Alcohol,2008,43(4):416-422.
|
[8]WELCH C,HARRISON D,SHORT A,et al.The increasing burden of alcoholic liver disease on United Kingdom critical care units:secondary analysis of a high quality clinical database[J].J Health Serv Res Policy,2008,13(Suppl 2):40-44.
|
[9]JIMBA S,NAKAGAMI T,TAKAHASHI M,et al.Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults[J].Diabet Med,2005,22(9):1141-1145.
|
[10]FAN JG,ZHU J,LI XJ,et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai,China[J].J Hepatol,2005,43(3):508-514.
|
[11]BROWNING JD,SZCZEPANIAK LS,DOBBINS R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology,2004,40(6):1387-1395.
|
[12]KAIBORI M,ISHIZAKI M,MATSUI K,et al.Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy[J].Am J Surg,2012,204(3):300-307.
|
[13]TAKEUCHI Y,IKEDA F,MORITOU Y,et al.The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis[J].J Gastroenterol,2013,48(3):405-412.
|
[14]KIM JM,KWON CH,JOH JW,et al.Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver[J].J Surg Oncol,2014,110(8):976-981.
|
[15]UTSUNOMIYA T,SHIMADA M,KUDO M,et al.A comparison of the surgical outcomes among patients with HBV-positive,HCVpositive,and non-b non-c hepatocellular carcinoma[J].Ann Surg,2015,261(3):513-520.
|
[16]ZHOU Y,SI X,WU L,et al.Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma:a meta-analysis of observational studies[J].World J Surg Oncol,2011,9:108.
|
[17]ERCOLANI G,GRAZI GL,RAVAIOLI M,et al.Liver resection for hepatocellular carcinoma on cirrhosis:univariate and multivariate analysis of risk factors for intrahepatic recurrence[J].Ann Surg,2003,237(4):536-543.
|
[18]NISHIO T,HATANO E,SAKURAI T,et al.Impact of hepatic steatosis on disease-free survival in patients with Non-B Non-C hepatocellular carcinoma undergoing hepatic resection[J].Ann Surg Oncol,2015,22(7):2226-2234.
|